# Qiagen N.v. (QGEN)

Source page: https://stoqly.net/companies/qgen

- **Ticker:** QGEN (NYSE)
- **Sector:** Health Care / Biological Products, (No Diagnostic Substances)
- **SEC CIK:** 0001015820
- **Latest annual report:** 20-F filed 2026-03-20 (https://www.sec.gov/Archives/edgar/data/1015820/000101582026000018/qgen-20251231.htm)
- **Data updated:** 2026-11-01

## Key figures

- **Last close:** $50.22 on 2026-10-30
- **Market cap:** $11.0B
- **P/E (trailing):** 25.9x
- **EPS, trailing 12 months:** $1.94
- **Revenue (FY2025):** $2.1B
- **Revenue growth:** +5.7%
- **Revenue growth, 5-year CAGR:** +2.2%
- **Gross margin:** 62.2%
- **Operating margin:** 22.3%
- **Net margin:** 20.3%
- **Free cash flow:** $453M
- **Free cash flow margin:** 21.7%
- **Return on invested capital:** 9.3%
- **Return on equity:** 11.6%
- **Net debt:** $556M
- **Net debt / EBITDA:** 0.8x
- **Change in share count:** −2.6%
- **Piotroski F-score:** 7/9
- **Insider buys, last 90 days:** $0.0M
- **Insider sells, last 90 days:** $0.0M

Definitions: https://stoqly.net/about

## Annual results

From SEC EDGAR XBRL filings. Full table: https://stoqly.net/companies/qgen/figures.csv

| US$ millions | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---:|---:|---:|---:|---:|---:|---:|---:|---:|---:|
| Revenue | 1,338 | 1,418 | 1,502 | 1,526 | 1,870 | 2,252 | 2,142 | 1,965 | 1,978 | 2,090 |
| Operating income | 99 | 153 | 267 | -26 | 386 | 630 | 531 | 410 | 98 | 466 |
| Net income | 80 | 40 | 190 | -41 | 359 | 513 | 423 | 341 | 84 | 425 |
| Diluted EPS (US$) | 0.34 | 0.17 | 0.82 | -0.18 | 1.53 | 2.21 | 1.84 | 1.48 | 0.37 | 1.94 |
| Operating cash flow | 342 | 287 | 359 | 331 | 458 | 639 | 715 | 459 | 674 | 654 |
| Free cash flow | 267 | 197 | 250 | 213 | 325 | 449 | 586 | 310 | 506 | 453 |
| Cash | 532 | 1,017 | 1,394 | 753 | 715 | 1,065 | 1,418 | 1,058 | 1,153 | 1,099 |
| Debt and leases | 1,067 | 1,758 | 2,174 | 1,706 | 1,923 | 1,942 | 1,861 | 1,510 | 1,392 | 1,654 |

---

Source: SEC EDGAR filings and end-of-day prices, via Stoqly. For information only — not investment advice or a recommendation to buy, sell or hold any security.